cytarabine has been researched along with Overweight in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ashizawa, M; Fujiwara, SI; Genda, H; Hatano, K; Ikeda, T; Ito, S; Kanda, Y; Kawaguchi, SI; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Ochi, SI; Oh, I; Ohmine, K; Sato, K; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
Abhyankar, S; Aljitawi, O; Bivona, C; Bray, WM; Ganguly, S; Grauer, D; Henry, D; Lin, TL; McGuirk, J; Rockey, M; Singh, A | 1 |
Balwierz, W; Bik-Multanowski, M; Galicka-Latala, D; Gozdzik, J; Pietrzyk, JJ; Strojny, W; Surmiak, M; Szymon, S | 1 |
3 other study(ies) available for cytarabine and Overweight
Article | Year |
---|---|
The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin.
Topics: Antineoplastic Agents; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Kidney Tubules; Lymphoma; Male; Overweight; Retrospective Studies; Risk Factors; Salvage Therapy | 2020 |
Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Weight; Cohort Studies; Cytarabine; Drug Dosage Calculations; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Obesity; Overweight; Recurrence; Remission Induction; Retrospective Studies; Young Adult | 2015 |
Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Genetic Association Studies; Homozygote; Humans; Male; Methotrexate; Obesity; Odds Ratio; Overweight; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proteins; Radiotherapy; Risk Factors; Survivors; Thioguanine; Vincristine; Young Adult | 2011 |